TCBT:F:F-VanEck Vectors ETFs N.V. - VanEck Vectors iBoxx EUR Corporates UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 17.156

Change

-0.02 (-0.11)%

Market Cap

USD 0.04B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.03 (-0.09%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.05 (+0.10%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.60 (+0.25%)

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.05B
VUSA:F Vanguard Funds Public Limited ..

+0.24 (+0.24%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.28 (+0.28%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 40.74B
0ZC:F Zscaler Inc

-3.78 (-2.48%)

USD 37.92B

ETFs Containing TCBT:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.85% 24% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.85% 21% F 39% F
Trailing 12 Months  
Capital Gain 8.23% 34% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.23% 30% F 43% F
Trailing 5 Years  
Capital Gain -8.96% 19% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.96% 19% F 25% F
Average Annual (5 Year Horizon)  
Capital Gain -2.33% N/A N/A 38% F
Dividend Return -2.33% N/A N/A 34% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.37% N/A N/A 95% A
Risk Adjusted Return -36.58% N/A N/A 27% F
Market Capitalization 0.04B 13% F 21% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.